Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...
CFO Beth Jantzen reported total revenues of $1.2 million for Q1 2025, a year-over-year increase driven by higher product revenue from DNA Tagging and increased isotopic testing services. Operating ...
Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...
Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...
scientists can modify the pig’s DNA. eGenesis workers make more than 60 edits to help manage a host of potential issues including rejection, size of the organ and even pig retroviruses that could ...
By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...
This manuscript describes an important finding of the transcriptional control of a chimeric gene transfer agents (GTA) cluster in Bartonella by a processive anti-termination factor (BrrG). The ...
The CBI team has uncovered a bribery case related to the National Assessment and Accreditation Council (NAAC) rating. During ...
Akribion Therapeutics (“Akribion”), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback